Signal transducer and activator of transcription-1 (STAT1), but not STAT5b, regulates IGF-I receptor gene expression in an osteosarcoma cell line

Journal of Pediatric Endocrinology and Metabolism

Volumn 17, Issue 2, 2004, Pages 211-218

  Shalita Chesner, Michal ^a   Glaser, Tova ^a   Werner, Haim ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cytokines; IGF; IGF I receptor; Interferon; Promoter; STAT; Transcription

Indexed keywords

CYTOKINE; GAMMA INTERFERON; LUCIFERASE; SOMATOMEDIN C; STAT1 PROTEIN; STAT5B PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; CELL LINE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MITOGENESIS; OSTEOSARCOMA CELL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 3142738046     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2004.17.2.211     Document Type: Article

References (37)

1. Werner H, LeRoith D. New concepts in regulation and function of the insulin-like growth factors: implications for understanding normal growth and neoplasia. Cell Mol Life Sci 2000; 57: 932-942.
2. Rosenfeld RG, Roberts CT Jr. The IGF System: Molecular Biology, Physiology, and Clinical Applications. Totowa, NJ: Humana Press, 1999.
3. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 1995; 16: 143-163.
4. Werner H. Molecular biology of the type 1 IGF receptor. In: Rosenfeld RG, Roberts CT Jr, eds. The IGF System: Molecular Biology, Physiology and Clinical Applications. Totowa, NJ: Humana Press, 1999; 63-88.
5. Pietrzkowski Z, Lammers R, Carpenter G, Soderquist AM, Limardo M, Phillips PD, Ullrich A, Baserga R. Constitutive expression of insulin-like growth factor I and insulin-like growth factor I receptor abrogates all requirements for exogenous growth factors. Cell Growth Diff 1992; 3: 199-205.
6. Minniti CP, Maggi M, Helman LJ. Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine growth loop. Cancer Res 1992; 52: 1830-1835.
7. Werner H, LeRoith D. The role of the insulin-like growth factor system in human cancer. Adv Cancer Res 1996; 68: 183-223.
8. Baserga R, Hongo A, Rubini M, Prisco M, Valentinis B. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta 1997; 1332: F105-F126.
9. Eshet R, Werner H, Klinger B, Silbergeld A, Laron Z, LeRoith D, Roberts CT Jr. Up-regulation of insulin-like growth factor-I (IGF-1) receptor gene expression in patients with reduced serum IGF-I levels. J Mol Endocrinol 1993; 10: 115-120.
10. Rosenfeld RG, Dollar LA. Characterization of the somatomedin-C/insulin-like growth factor I (SM-C/IGF-I) receptor on cultured human fibroblast monolayers: regulation of receptor concentration by SM-C/IGF-I and insulin. J Clin Endocrinol Metab 1982; 55: 434-440.
11. Rubini M, Werner H, Gandini E, Roberts CT Jr, LeRoith D, Baserga R. Platelet-derived growth factor increases the activity of the promoter of the IGF-I receptor gene. Exp Cell Res 1994; 211: 374-379.
12. Hernandez-Sanchez C, Werner H, Roberts CT Jr, Woo EJ, Hun DW, Rosenthal SM, LeRoith D. Differential regulation of IGF-I receptor gene expression by IGF-I and basic fibroblast growth factor. J Biol Chem 1997; 272: 4663-4670.
13. Tracey KJ, Cerami A. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 1993; 9: 317-343.
14. Shalita-Chesner M, Katz J, Shemer J, Werner H. Regulation of insulin-like growth factor-I receptor gene expression by tumor necrosis factor-α and interferon-γ. Mol Cell Endocrinol 2001; 176: 1-12.
15. Darnell JE, Kerr IM, Stark GR. Jak-Stat pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264: 1415-1421.
16. Watanabe S, Arai K. Roles of the JAK-STAT system in signal transduction via cytokine receptors. Curr Opin Gen Dev 1996; 6: 587-596.
17. Touw IP, De Koning JP, Ward AC, Hermans MHA. Signaling mechanisms of cytokine receptors and their perturbances in disease. Mol Cell Endocrinol 2000; 160: 1-9.
18. Qureshi SA, Leung S, Kerr IM, Stark GR, Darnell JE Jr. Function of Stat2 protein in transcriptional activation by alpha interferon. Mol Cell Biol 1996; 16: 288-293.
19. Seidel HM, Milocco LH, Lamb P, Darnell JE Jr, Stein RB, Rosen J. Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc Natl Acad Sci USA 1995; 92: 3041-3045.
20. Ihle JN. STATs: signal transducers and activators of transcription. Cell 1996; 84: 331-334.
21. Darnell JE Jr. STATs and gene regulation. Science 1997; 277: 1630-1635.
22. Werner H, Karnieli E, Rauscher FJ III, LeRoith D. Wild type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc Natl Acad Sci USA 1996; 93: 8318-8323.
23. Ohlsson C, Kley N, Werner H, LeRoith D. p53 regulates IGF-I receptor expression and IGF-I induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between p53 and Sp1. Endocrinology 1998; 139: 1101-1107.
24. Werner H, Rauscher FJ III, Sukhatme VP, Drummond IA, Roberts CT Jr, LeRoith D. Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site. J Biol Chem 1994; 269: 12577-12582.
25. Werner H, Bach MA, Stannard B, Roberts CT Jr, LeRoith D. Structural and functional analysis of the insulin-like growth factor I receptor gene promoter. Mol Endocrinol 1992; 6: 1545-1558.
26. Ilvesmaki V, Jaattela M, Saksela E, Voutilainen R. Tumor necrosis factor-α and interferon-γ inhibit insulin-like growth factor II gene expression in human fetal adrenal cell cultures. Mol Cell Endocrinol 1993; 91: 59-65.
27. Arkins S, Rebeiz N, Brunke-Reese DB, Biragyn A, Kelley KW. Interferon-γ inhibits macrophage insulin-like growth factor-I synthesis at the transcriptional level. Mol Endocrinol 1995; 9: 350-360.
28. Bird JL, Tyler JA. Tumor necrosis factor α, interferon γ and dexamethasone regulate IGF-I-maintained collagen production in cultured human fibroblasts. J Endocrinol 1995; 147: 167-176.
29. Katz J, Nasatzky E, Werner H, LeRoith D, Shemer J. Tumor necrosis factor α and interferon γ-induced cell growth arrest is mediated via insulin-like growth factor binding protein-3. Growth Horm IGF Res 1999; 9: 174-178.
30. Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ, Davey HW. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA 1997; 94: 7239-7244.
31. Levy DE, Gilliland DG. Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice. Oncogene 2000; 19: 2505-2510.
32. Baserga R. The IGF-I receptor in cancer research. Exp Cell Res 1999; 253: 1-6.
33. Resnicoff M, Abraham D, Yutanawiboonchai W, Rotman HL, Kajstura J, Rubin R, Zoltick P, Baserga R. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res 1995; 55: 2463-2469.
34. Huang S, Bucana CD, Van Arsdall M, Fidler IJ. Stat1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells. Oncogene 2002; 21: 2504-2512.
35. Bowman T, Garcia R, Turkson J, Jove R. STATs in oncogenesis. Oncogene 2000; 19: 2474-2488.
36. Bellido T, O'Brien CA, Roberson PK, Manolagas SC. Transcriptional activation of the p21 (WAF1, CIP1, SDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells. J Biol Chem 1998; 273: 21137-21144.
37. Werner H, Re GG, Drummond IA, Sukhatme VP, Rauscher FJ III, Sens DA, Garvin AJ, LeRoith D, Roberts CT Jr. Increased expression of the insulin-like growth factor-I receptor gene, IGFIR, in Wilms' tumor is correlated with modulation of IGFIR promoter activity by the WT1 Wilms' tumor gene product. Proc Natl Acad Sci USA 1993; 90: 5828-5832.